24 Sep, 2018 – UTILITY therapeutics Appoints Francesco Granata as Chairman
19 Sep, 2018 – UTILITY receives Investigational New Drug Approval from US FDA
16 July, 2018 – UTILITY receives Qualified Infectious Disease Product designation for uncomplicated urinary tract infections from US FDA
21 May, 2018 – UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDA
15 May, 2018 – UTILITY therapeutics signs license agreement with LEO Pharma A/S for US rights to mecillinam and pivmecillinam
